Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T12:45:54.338Z.
Calculation as of: 2026-10-06T12:45:54.338Z.
Quote observation: 2026-10-05T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9b4bc62a31f75b1a016fc6ea0dc71fcb65437a541a8d62a03c8decabfd044c64
EARNINGS YIELD
N/A
Cardio Diagnostics Holdings, Inc.
Market Cap
$6.10M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.09M
Earnings Yield
148486.19%
TTM Avg
20265.03%
3Y Avg
20265.03%
5Y Avg
20265.03%
Market Cap
$6.03M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.44M
Earnings Yield
N/A
TTM Avg
0.03%
3Y Avg
0.01%
5Y Avg
0.01%
Market Cap
$5.54M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | $6.10M | N/A | N/A | N/A | N/A |
| Femasys Inc. (FEMY)vs › | $6.10M | N/A | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $6.09M | 148486.19% | 20265.03% | 20265.03% | 20265.03% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $6.03M | N/A | N/A | N/A | N/A |
| Biomerica, Inc. (BMRA)vs › | $6.34M | N/A | 0.84% | 1.16% | 1.47% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.44M | N/A | 0.03% | 0.01% | 0.01% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | N/A | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.54M | N/A | N/A | N/A | N/A |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.72M | N/A | N/A | N/A | N/A |
| Aclarion, Inc. (ACON)vs › | $6.74M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute